guidance

Here’s why one analyst advises, “Don’t bet against Michael Dell.”

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.

Adtalem raises FY2025 EPS guidance to $6.10-$6.30 with 9%-11% revenue growth

Jan. 16, 2025 6:55 PM ETUnited States Natural Gas Fund, LP ETF (UNG), NG1:COMUCO, USO, DBO, FCG, USL, SCO, UNL, BNO, BOIL, KOLD, GUSH, DRIP, USOI, CO1:COM, CL1:COMBy: Carl Surran,…

Jan. 11, 2025 9:10 PM ETBunge Global SA (BG) Stock, VLO StockPBW, GPRE, DAR, CLNE, ERTH, QCLN, SMOG, PBD, ICLN, REX, GEVO, BE, CNRG, ACESBy: Carl Surran, SA News Editor…